Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study
Date issued
2013Journal title
Journal Of Clinical Oncology
Type of content
Publicación de congreso